BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 12597922)

  • 21. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects.
    Sledge GW
    Semin Oncol; 2002 Jun; 29(3 Suppl 11):104-10. PubMed ID: 12138404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
    Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
    Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cell biology of intraocular vascular diseases].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biology of VEGF and its receptors.
    Ferrara N; Gerber HP; LeCouter J
    Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma.
    Vacca A; Ria R; Ribatti D; Semeraro F; Djonov V; Di Raimondo F; Dammacco F
    Haematologica; 2003 Feb; 88(2):176-85. PubMed ID: 12604407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of vascular endothelial growth factor in angiogenesis.
    Ferrara N; Gerber HP
    Acta Haematol; 2001; 106(4):148-56. PubMed ID: 11815711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
    Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD
    Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of vascular endothelial growth factor in the regulation of angiogenesis.
    Ferrara N
    Kidney Int; 1999 Sep; 56(3):794-814. PubMed ID: 10469350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis.
    Kang DH; Johnson RJ
    Curr Opin Nephrol Hypertens; 2003 Jan; 12(1):43-9. PubMed ID: 12496665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lymphangiogenesis and biological activity ov vascular endothelial growth factor-C].
    Mandriota SJ; Pepper MS
    J Soc Biol; 1999; 193(2):159-63. PubMed ID: 10451350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of microvascular permeability by vascular endothelial growth factors.
    Bates DO; Hillman NJ; Williams B; Neal CR; Pocock TM
    J Anat; 2002 Jun; 200(6):581-97. PubMed ID: 12162726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor and its receptors.
    Klagsbrun M; D'Amore PA
    Cytokine Growth Factor Rev; 1996 Oct; 7(3):259-70. PubMed ID: 8971481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development.
    Sepp-Lorenzino L; Thomas KA
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1447-65. PubMed ID: 12387705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of vascular permeability factor/vascular endothelial growth factor in eye disease.
    Schlingemann RO; van Hinsbergh VW
    Br J Ophthalmol; 1997 Jun; 81(6):501-12. PubMed ID: 9274417
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas.
    Donnini S; Machein MR; Plate KH; Weich HA
    J Pathol; 1999 Sep; 189(1):66-71. PubMed ID: 10451490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?].
    Joussen AM; Kirchhof B; Gottstein C
    Ophthalmologe; 2003 Apr; 100(4):284-91. PubMed ID: 12682760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.